Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuation

INTRODUCTION: In this study, we evaluated the clinical relevance of serum drug levels and antidrug antibodies (ADAbs) with regard to response to treatment, as well as to relapse upon treatment discontinuation, in peripheral spondyloarthritis (pSpA) patients treated with adalimumab. METHODS: The stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Paramarta, Jacqueline E, Baeten, Dominique L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261980/
https://www.ncbi.nlm.nih.gov/pubmed/25074046
http://dx.doi.org/10.1186/ar4675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261980/
https://www.ncbi.nlm.nih.gov/pubmed/25074046
http://dx.doi.org/10.1186/ar4675

Ejemplares similares